Costa Rica's Medtech Shift: From Assembly to Innovation

Jan de Vries · 2026-11-06

Costa Rica isn't just assembling medical devices anymore. It's designing them, engineering them, and moving up the value chain in a big way. If you've been watching the medtech manufacturing landscape, you've probably noticed the country quietly transforming itself from a low-cost assembly hub into a genuine innovation partner. And that shift has real implications for startups and investors on both sides of the Atlantic. ### The Evolution of a Medtech Hub For years, Costa Rica was known for its medical device manufacturing—think catheters, surgical instruments, and disposable products. Companies like Medtronic, Baxter, and Abbott set up shop there to take advantage of skilled labor and favorable trade agreements. But now, the country is betting on a bigger piece of the pie: engineering and R&D. "We're not just making devices anymore; we're designing them," says a local industry insider. "The talent is here, and the infrastructure is catching up." That means more high-paying jobs, more intellectual property, and a stronger ecosystem for medtech startups. The government has been actively courting companies that want to do more than assemble—they want to innovate. ### What's Driving the Change? Several factors are fueling this shift: - **Talent pool:** Costa Rica has a growing number of engineers and technicians trained in biomedical fields. Universities are partnering with industry to create specialized programs. - **Supplier network:** Local suppliers are stepping up their game, offering precision components and services that were once imported. - **Digital capabilities:** From software development to data analytics, Costa Rica is building the digital backbone that modern medtech requires. It's a classic case of moving up the value chain. Instead of competing on cost alone, the country is competing on capability. ### Why It Matters for Startups For European startups, this could mean new opportunities for collaboration. Imagine a Dutch or German medtech startup partnering with a Costa Rican engineering firm to develop a prototype faster and cheaper than they could at home. Or a US-based company setting up a nearshore R&D center to tap into the time zone and talent. And with the EU Inc proposal on the horizon—aimed at simplifying cross-border incorporation for European startups—Costa Rica's medtech ambitions could align nicely. European companies looking to expand their manufacturing or R&D footprint might find Costa Rica an attractive base, especially with the EU's push for more integrated markets. ### The Road Ahead Of course, challenges remain. Infrastructure gaps, regulatory hurdles, and competition from other nearshore destinations like Mexico and Colombia are real. But Costa Rica's bet on engineering and digital capabilities seems well-timed. As medtech becomes more software-driven and personalized, the countries that can offer both manufacturing and innovation will win. So next time you think of Costa Rica, don't just think of beaches and coffee. Think of the engineers designing the next generation of medical devices—and the startups that might just follow them there.